Cargando…
Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique
Autores principales: | Kromdijk, W., Sikma, M. A., van den Broek, M. P. H., Beijnen, J. H., Huitema, A. D. R., de Lange, D. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095329/ https://www.ncbi.nlm.nih.gov/pubmed/23443310 http://dx.doi.org/10.1007/s00134-013-2851-x |
Ejemplares similares
-
Oseltamivir carboxylate accumulation in a patient treated by haemodiafiltration and extracorporeal membrane oxygenation
por: Lemaitre, Florian, et al.
Publicado: (2010) -
Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non‐obese volunteers
por: Chairat, Kalayanee, et al.
Publicado: (2016) -
Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir
por: Meijer, Wouter J., et al.
Publicado: (2015) -
Plasma Concentrations of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Children on Extracorporeal Membrane Oxygenation Support
por: Wildschut, Enno D., et al.
Publicado: (2010) -
Increased unbound drug fraction in acute carbamazepine intoxication: suitability and effectiveness of high-flux haemodialysis
por: Sikma, M. A., et al.
Publicado: (2012)